Acute Lymphoblastic Leukemia Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.H19 in Acute Lymphoblastic Leukemia.
Condition: Acute Lymphoid Leukemia Intervention: Sponsor: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials
Research Development （RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7（CD7）+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML)
Conditions: Neoplasms; Hematologic Neoplasms; Hematologic Diseases Intervention: Drug: RD13-02 cell infusion Sponsors: Kai Lin Xu，MD; Nanjing Bioheng Biotech Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials
